CIMT 2018 Annual Meeting

Tuesday 15th May 2018 at Mainz, Germany

 

Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT 2018 invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

 

 

For 2018, the CIMT program committee is preparing plenary sessions from pre-clinical research to clinical development on the topics of therapeutic vaccination, cellular therapy, improving immunity, tumor microenvironment, antibodies, regulatory research and immunoguiding. The plenary sessions will be complemented by a poster exhibit and selected poster short talk sessions, as well as industry symposia and industry exhibits.

CIMT selects young scientists from underrepresented countries for travel awards of 350 EUR plus free conference admission to offset meeting-related expenses.
Travel awards can only be issued to scientists who have submitted an abstract and are registered to attend the meeting.

More information on the scientific program, call for abstracts and travel award applications on http://www.meeting.cimt.eu/


Event Details


Upcoming Events

World Immune Regulation Meeting XVIII

Wednesday 13th March 2024

Global Transformations and Türkiye

Thursday 18th April 2024

2024 Day of Immunology

Monday 29th April 2024

17th International Congress on Toxoplasmosis

Sunday 26th May 2024 at Harnack-Haus

7th World Bronchiectasis Conference

Thursday 4th July 2024

8th European Veterinary Immunology Workshop

Wednesday 4th September 2024 at Crowne Plaza Dublin Airport

18th Vaccine Congress

Sunday 8th September 2024 at Altis Grand Hotel

57th Annual Meeting of the German Society for Transfusion Medicine and Immunohaematology (DGTI) together with the 31st Annual Meeting of the German Society for Immunogenetics (DGI)

Wednesday 11th September 2024

SLB 2024: Not Lost in Translation: Innate and Adaptive Immunity

Monday 21st October 2024Society for Leukocyte Biology